The Phase III VALUE clinical trial for a product developed by MediWound Ltd. is underway, involving a BARDA contract and sites across multiple countries, including the U.S. and Europe.
1 report, 1 independent
Updated May 27
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The Phase III VALUE clinical trial for a product developed by MediWound Ltd. is underway, involving a BARDA contract and sites across multiple countries, including the U.S. and Europe.
How it developed
Newest first. Tap a step to see who reported it.- MediWound announced findings from its clinical trial conducted in Yavne.Sub-event
- MediWound and NexoBrid participated in the EBA Congress, which was held in Berlin, Germany, in September 2025.Sub-event
Phase III clinical trial for MediWound product underway, tied to BARDA contract, with sites in the U.S. and Europe.1 source